Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Recursion Pharmaceuticals Inc’s current trading price is -47.49% away from its 52-week high, while its distance from the 52-week low is 71.24%. The stock’s price range during this period has varied between $3.79 and $12.36. The company, active in the Healthcare sector, saw a trading volume of around 23.45 million for the day, considerably lower average daily volume of 27.83 million observed over the last three months.
Currently, the stock price of Recursion Pharmaceuticals Inc (RXRX) is $6.49. In the most recent trading session, the stock underwent a significant upswing, peaking at $10.0 after opening at $6.49. The stock touched a low of $4.0 before closing at $6.26.
Recursion Pharmaceuticals Inc had a pretty Dodgy run when it comes to the market performance. Over the past year, the company’s stock reached a high of $12.36 on 02/18/25, while the lowest price during the same period was $3.79 on 04/09/25.
How Financial Performance Impacts Market Capitalization
Recursion Pharmaceuticals Inc (RXRX) has experienced a quarterly rise of 12.87% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.80B.
Decoding Analysts’ Ratings for Recursion Pharmaceuticals Inc
As of right now, 1 analyst is rating Recursion Pharmaceuticals Inc as a BUY, 1 of the polled analysts branded the stock as an OVERWEIGHT, 6 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 5.32, with a change in price of -0.10. Similarly, Recursion Pharmaceuticals Inc recorded 25,294,684 in trading volume during the last 100 days, posting a change of -1.52%.
How RXRX’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for RXRX stands at 0.10. Similarly, the long-term debt-to-equity ratio is also 0.08.
RXRX Stock Stochastic Average
As of today, the raw stochastic average of Recursion Pharmaceuticals Inc over the last 50 days is at 79.31%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 71.91%. Further, the company’s Stochastic %K and %D values for the last 20 days were 67.80% and 69.05%, respectively.
RXRX Stock Price Performance Analysis
Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. This year’s metric has recorded a Price decrease of -24.36%. However, over the past six months, we’ve seen a stronger performance of -13.81%. The price of RXRX fallen by 25.78% over the last 30 days. And in the last five days, it has surged by 11.13%.
